Contemporary Understanding of Diagnosis and Treatment of Children with Cystic Fibrosi
https://doi.org/10.15690/pf.v12i5.1462
Abstract
The issue of contemporary diagnosis and correct management of patients with cystic fibrosis is relevant not only for Russia, but for the entire world. Despite achievements of the contemporary medical science, underdiagnosis of this systemic genetic disorder leading to severe incapacitation and death of pulmonary and heart failure in the vast majority of cases is still observed. The burden induced by this disease is so severe that neonatal screening has been introduced to suspect and detect disease and start pathogenetic treatment capable of stopping or slowing progression of the disease as soon as possible. Apart from the contemporary classification and diagnostic criteria, the article presents treatment goals and components requiring a multidisciplinary approach in detail. Specific attention is given to methods of kinesitherapy, use of antibacterial drugs and enzyme replacement therapy, which primarily determine prognosis of the disease.
About the Authors
A. A. BaranovRussian Federation
L. S. Namazova-Baranova
Russian Federation
O. I. Simonova
Russian Federation
N. Y. Kashirskaya
Russian Federation
E. A. Roslavtseva
Russian Federation
Y. V. Gorinova
Russian Federation
S. A. Krasovskiy
Russian Federation
L. R. Selimzyanova
Russian Federation
References
1. Муковисцидоз. Под ред. Н.И.Капранова, Н.Ю.Каширской. Москва: Медпрактика-М. 2014. 672 с.
2. Flume PA, Mogayzel PJ, Robinson KA. Cystic Fibrosis Pulmonary Guidelines: Treatment of Pulmonary Exacerbations. Am J Respir Crit Care Med. 2009;180:802–808.
3. Mogayzel PJ, Naureckas ET, Robinson KA. Cystic Fibrosis Pulmonary Guidelines. Am J Respir Crit Care Med. 2013;187:680–689.
4. Ratjen F, Munck A, Kho P, Angyalosi G. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial. Thorax. 2010;65(4):286–291.
5. Taccetti G, Bianchini E, Cariani L. Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: A randomised multicentre study comparing two different protocols. Thorax. 2012;67(10):853–859.
6. Proesmans M, Vermeulen F, Boulanger L, Verhaegen J, De Boeck K. Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis. J Cyst Fibros. 2013;12(1):29–34.
7. Smyth R, Bell SC, Bojcin S, Bryon M, Duff A, Flume PA. European Cystic Fibrosis Society Standards of Care: Best Practice guidelines. J Cyst Fibrosis. 2014;13:S23–S42.
8. Национальный консенсус по муковисцидозу. Раздел «Антимикробная терапия». Педиатрия. Журнал имени Г. Н. Сперанского. 2014;93(4):107–122.
9. Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Heijerman GM. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibrosis. 2002;1:51–75.
10. Bilton D, Bellon G, Charlton B, Cooper P, De Boeck K, Flume PA. Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosis. J Cyst Fibrosis. 2013; 12:367–376.
Review
For citations:
Baranov A.A., Namazova-Baranova L.S., Simonova O.I., Kashirskaya N.Y., Roslavtseva E.A., Gorinova Y.V., Krasovskiy S.A., Selimzyanova L.R. Contemporary Understanding of Diagnosis and Treatment of Children with Cystic Fibrosi. Pediatric pharmacology. 2015;12(5):589-604. (In Russ.) https://doi.org/10.15690/pf.v12i5.1462